The International Publication Planning Meeting (TIPPA) is a community of senior-level stakeholders in the publication planning space convening to exchange off-the record ideas and benchmark best practices with industry peers from pharmaceutical, biotech and medical device/diagnostic companies, as well as publishers and academia. Our unique, intimate atmosphere creates an open dialogue arming attendees with competitive advantage strategies, benchmarking techniques, and best practices to ensure their organization executes a successful and compliant publication plan.
Our February 2020 event will be back on the West Coast to build on those themes and introduce new provocative topics that lend themselves to the safe, interactive idea-exchange environment RISE has cultivated at TIPPA for the last 18 years. We'll be discussing the most pressing topics impacting scientific communication including regulatory, technological and publishing trends.
This conference brings together global stakeholders in biopharma, medical device/diagnostics, agencies and publishers to learn, network and discuss the latest trends impacting the dissemination of scientific communication to patients and HCPs.
Mix and mingle with senior leaders from pharmaceutical, biotech and medical device & diagnostic companies, including those with job functions relating to Medical Affairs, Scientific/Medical Communication, Medical Strategy and Publication Planning. In addition, network with mid- to senior level professionals at medical communication, education or publication planning agencies and suppliers working in medical communication, publication planning and technology, as well as vendors, consultants and members of academia.
Check out what attendees gained from attending our Spring 2019 conference:
Check out our brochure and get an idea of what's to come in February 2020.
Interested in sponsoring TIPPA? Submit an inquiry and a representative will reach out to you shortly.
Become a RISE Association member to get the most relevant industry news & educational opportunities
FISHAWACK
ALNYLAM PHARMACEUTICALS
TAKEDA
RELYPSA
